Brainscapes PIs join AI in Computational Life-Science program to enhance drug discovery in the brain

The possibilities to access the molecular data of cells and tissues are increasing, but this also creates new challenges. In drug discovery, for example, how can one find druggable targets for research when there is such an enormous amount of data? The scientific program Medical Delta AI for Computational Life Sciences uses AI techniques to unlock biomedical data, discover new candidate drugs, detect special cell abnormalities or connections, and find useful information for drug research. In the development of new medicines for brain disorders for example, it has proven difficult to translate findings from laboratory animal research directly into the effects of drugs on humans. As a first step towards valorization of Brainscapes research, two Brainscapes PI’s Lelieveldt and Reinders joint this program to leverage Brainscapes research on cross-species comparison of single-cell multi-omics data resources¬† to improve the translation of pre-clinical research findings from mouse to human.

More information on the AI for Computational Life-Science program, can be found here.

Professor Lelieveldt (left) and Professor Reinders (right).